Emerson (EMR) shares tumbled 5.31% in pre-market trading on Wednesday following the release of its third-quarter 2025 financial results and updated full-year guidance. The industrial technology company's performance and outlook appear to have disappointed investors, leading to the significant stock decline.
For the third quarter, Emerson reported sales of $4.553 billion, falling short of the $4.597 billion estimated by analysts. While the company's adjusted earnings per share (EPS) of $1.52 slightly beat the consensus estimate of $1.51, the revenue miss seems to have overshadowed this positive aspect. Emerson's GAAP EPS for the quarter stood at $1.03, with operating cash flow reaching $1.062 billion.
Adding to investor concerns, Emerson updated its full-year 2025 outlook, now projecting revenue growth of 3.5% and adjusted EPS of $6.00. This guidance may be viewed as conservative by some market participants. For the upcoming fourth quarter, the company expects net sales growth of 5.5% to 6.5% and underlying sales growth of 5% to 6%. The tempered outlook, combined with the Q3 sales miss, appears to be the primary driver behind the stock's pre-market plunge as investors reassess Emerson's growth prospects in the current economic environment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.